Expanding the clinical spectrum of anti‐IgLON5 disease: A multicenter retrospective study
- 20 September 2021
- journal article
- research article
- Published by Wiley in European Journal of Neurology
- Vol. 29 (1) , 267-276
Abstract
Background: We conducted this study to describe detailed the clinical characteristics, ancillary test results and treatment response of a group of Chinese patients with anti‐IgLON5 disease.Methods: We recruited 13 patients with positive IgLON5 antibodies in serum and/or cerebrospinal fluid from nine tertiary referral centers. Patients were enrolled from February 2017 to July 2021. We retrospectively collected information on the presenting and main symptoms, treatment response and follow‐up outcomes.Results: The median age of onset for symptoms was 60 (range: 33–73) years and six of the 13 patients were females. The predominant clinical presentations included sleep disturbance (eight patients) and cognitive impairment (seven patients), followed by movement disorders (six patients). Parainfectious cause seemed plausible. Notably, we identified the first case of possible Epstein‐Barr virus (EBV)‐related anti‐IgLON5 disease. Coexisting neural autoantibodies were identified in two patients. Furthermore, two patients had other autoimmune diseases. The IgG subclass was determined in four patients, including two with dominant IgG4 subtype and two with dominant IgG1 subtype. Additionally, 10 patients were treated with immunotherapy and four patients exhibited improvement. Overall, six of 10 patients for whom follow‐up results were assessable had favorable clinical outcomes (modified Rankin Scale score ≤2).Conclusions: The clinical spectrum of anti‐IgLON5 disease is variable. Our results highlight a boarder spectrum of anti‐IgLON5 disease.Keywords
This publication has 23 references indexed in Scilit:
- Infection-triggered autoimmunityNeurology Neuroimmunology & Neuroinflammation, 2018
- Anti-NMDA receptor encephalitis and nonencephalitic HSV-1 infectionNeurology Neuroimmunology & Neuroinflammation, 2018
- IgLON5-Associated Encephalitis With Atypical Brain Magnetic Resonance Imaging and Cerebrospinal Fluid ChangesFrontiers in Neurology, 2018
- IgLON5 antibodyNeurology Neuroimmunology & Neuroinflammation, 2017
- Clinical manifestations of the anti-IgLON5 diseaseNeurology, 2017
- Herpes simplex virus‐induced anti‐N‐methyl‐d‐aspartate receptor encephalitis: a systematic literature review with analysis of 43 casesDevelopmental Medicine & Child Neurology, 2017
- Cellular investigations with human antibodies associated with the anti-IgLON5 syndromeJournal of Neuroinflammation, 2016
- Neuropathological criteria of anti-IgLON5-related tauopathyActa Neuropathologica, 2016
- The expanding field of IgG4‐mediated neurological autoimmune disordersEuropean Journal of Neurology, 2015
- A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem studyThe Lancet Neurology, 2014